Advertisement

Topics

F.D.A. Names and Shames Drug Makers to Encourage Generic Competition

13:02 EDT 17 May 2018 | The New York Times News

In its campaign to lower drug prices, the agency posted a list of brand-name manufacturers in an effort to force them to share drug samples with their generic rivals.

Original Article: F.D.A. Names and Shames Drug Makers to Encourage Generic Competition

NEXT ARTICLE

More From BioPortfolio on "F.D.A. Names and Shames Drug Makers to Encourage Generic Competition"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Generics Drugs
A generic drug (generic drugs, short: generics) is a drug defined as "a drug product that is comparable to brand/reference listed drug product in dosage form, strength, route of administration, quality and performance characteristics, and intended u...